Pancreatic Cancer Research

ResearcherJinan UniversityActive in the last 2 years

Lisheng Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5965-308X; OpenAlex author ID A5100713993. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 2 papers · 2023: none · 2024: 2 papers

Papers 5

  1. Early detection of pancreatic cancer in patients with recurrent pancreatitis: A case report. Co-author DOI 10.12998/wjcc.v12.i19.3936↗
  2. CPEB1 Controls NRF2 Proteostasis and Ferroptosis Susceptibility in Pancreatic Cancer. Co-author DOI 10.7150/ijbs.95962↗
  3. MicroRNA MiR-490-5p suppresses pancreatic cancer through regulating epithelial-mesenchymal transition via targeting MAGI2 antisense RNA 3. Co-author DOI 10.1080/21655979.2021.2024653↗
  4. Exosomal LINC00460/miR-503-5p/ANLN positive feedback loop aggravates pancreatic cancer progression through regulating T cell-mediated cytotoxicity and PD-1 che… Last author DOI 10.1186/s12935-022-02741-5↗
  5. Bioinformatic Analysis Suggests That Three Hub Genes May Be a Vital Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1089/cmb.2019.0367↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Defeng Li · 3 shared papers, 2020–2024 · strength 0.52
  2. Zhenglei Xu · 2 shared papers, 2022 · strength 0.30
  3. Jun Yao · 2 shared papers, 2020–2022 · strength 0.26
  4. Cheng Wei · 1 shared paper, 2024 · strength 0.26
  5. Jun Yao · 1 shared paper, 2024 · strength 0.26
  6. Yuling Sheng · 1 shared paper, 2024 · strength 0.17
  7. Changzheng Du · 1 shared paper, 2024 · strength 0.17
  8. Shuxia Zhang · 1 shared paper, 2024 · strength 0.17
  9. Yingcai Hong · 1 shared paper, 2022 · strength 0.16
  10. Xin Chang · 1 shared paper, 2020 · strength 0.13
  11. Zhaoshen Li · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.